Last $8.20 USD
Change Today +0.241 / 3.03%
Volume 999.0
MGCD On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 9:35 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

mgc diagnostics corp (MGCD) Snapshot

Open
$8.20
Previous Close
$7.96
Day High
$8.20
Day Low
$8.20
52 Week High
11/21/13 - $13.51
52 Week Low
06/13/14 - $7.55
Market Cap
34.8M
Average Volume 10 Days
15.2K
EPS TTM
$0.37
Shares Outstanding
4.2M
EX-Date
04/10/13
P/E TM
22.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for MGC DIAGNOSTICS CORP (MGCD)

Related News

No related news articles were found.

mgc diagnostics corp (MGCD) Related Businessweek News

No Related Businessweek News Found

mgc diagnostics corp (MGCD) Details

MGC Diagnostics Corporation designs and markets non-invasive cardiorespiratory diagnostic products under the MGC Diagnostics and MedGraphics brand and trade names in the United States and internationally. It primarily offers pulmonary function products that include Spirometry, Complete Pulmonary Function Ultima PF, and Body Plethysmography product categories, which enable the early detection of lung disease; evaluating the effect of medication; monitoring patients with chronic disease; diagnosing lung diseases, such as asthma, emphysema, and bronchitis/chronic obstructive pulmonary disease; managing treatment; assessing the surgical risk of lung transplant and lung reduction candidates; and evaluating the impact of diseases, such as neuromuscular disease on breathing. The company also provides cardiopulmonary exercise testing products that measure functional capacity, fitness, or conditioning levels; and evaluate prognostic criteria for surgical procedures, as well as help physicians diagnose heart and lung diseases. In addition, it offers cycle ergometers and treadmills for use in diagnostic, rehabilitation, and sports medicine applications; and electronic medical records interfaces, such as BreezeConnect HL7 interface technology software, installation, and support for communications interfaces. MGC Diagnostics Corporation sells its products through a direct sales force and distributors to hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers, and clinical research organizations. The company was formerly known as Angeion Corporation and changed its name to MGC Diagnostics Corporation in August 2012. MGC Diagnostics Corporation was founded in 1986 and is headquartered in Saint Paul, Minnesota.

121 Employees
Last Reported Date: 01/28/14
Founded in 1986

mgc diagnostics corp (MGCD) Top Compensated Officers

Chief Financial Officer and Chief Operating O...
Total Annual Compensation: $157.9K
Compensation as of Fiscal Year 2013.

mgc diagnostics corp (MGCD) Key Developments

MGC Diagnostics Corporation and Medical Graphic Corporation Enter into a Credit Agreement with BMO Harris Bank NA

On July 24, 2014 MGC Diagnostics Corporation and its wholly owned subsidiary Medical Graphic Corporation entered into a credit agreement with BMO Harris Bank NA. The agreement includes a $4.0 million term loan and $3.0 million revolving credit facility that includes a $500,000 sub-limit for the issuance of standby and commercial letters of credit. The term loan, which bears interest at a floating rate currently equal to 5.0%, is amortized over a five-year period ending July 24, 2019 and is evidenced by a term note. The company funded the original $4.0 million under the term loan on July 24, 2014. The company is using these proceeds in connection with its acquisition of Medisoft SA, which the company expects to close on August 1, 2014. The revolving credit facility has a one-year term. The company anticipates it will renew the revolving credit facility after this initial one-year term. The company may use the revolving credit facility from time to time for working capital or general corporate needs. The revolving credit facility is evidenced by a revolving note.

MGC Diagnostics Corporation Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended Apr. 30, 2014

MGC Diagnostics Corporation announced unaudited consolidated earnings results for second quarter and six months ended Apr. 30, 2014. For the quarter, the company reported revenues of $7,427,000, operating income of $327,000, income before taxes of $327,000, net income of $308,000 or $0.07 per basic and diluted share compared to the revenues of $7,563,000, operating income of $258,000, income before taxes of $259,000, net income of $252,000 or $0.06 per basic and diluted share for the same quarter a year ago. For the six months period, the company reported revenues of $13,731,000, operating income of $101,000, income before taxes of $101,000, net income of $65,000 or $0.02 per basic and diluted share, net cash provided by operating activities of $1,408,000, purchases of property and equipment and intangible assets of $611,000 compared to the revenues of $14,571,000, operating loss of $118,000, loss before taxes of $117,000, net loss of $131,000 or $0.03 per basic and diluted share, net cash provided by operating activities of $511,000, purchases of property and equipment and intangible assets of $598,000 for the same period a year ago.

MGC Diagnostics Corporation to Report Q2, 2014 Results on Jun 12, 2014

MGC Diagnostics Corporation announced that they will report Q2, 2014 results at 5:00 PM, Eastern Standard Time on Jun 12, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MGCD:US $8.20 USD +0.241

MGCD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MGCD.
View Industry Companies
 

Industry Analysis

MGCD

Industry Average

Valuation MGCD Industry Range
Price/Earnings 21.6x
Price/Sales 1.1x
Price/Book 2.1x
Price/Cash Flow 21.4x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MGC DIAGNOSTICS CORP, please visit www.mgcdiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.